Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
0.803
+0.047 (6.26%)
At close: Nov 20, 2024, 4:00 PM
0.775
-0.027 (-3.38%)
After-hours: Nov 20, 2024, 7:27 PM EST
Neuronetics Employees
Neuronetics had 203 employees as of December 31, 2023. The number of employees increased by 9 or 4.64% compared to the previous year.
Employees
203
Change (1Y)
9
Growth (1Y)
4.64%
Revenue / Employee
$358,182
Profits / Employee
-$179,424
Market Cap
24.35M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Bionano Genomics | 344 |
Bolt Biotherapeutics | 100 |
BioXcel Therapeutics | 74 |
Enlivex Therapeutics | 71 |
Inspira Technologies Oxy B.H.N. | 42 |
Chemomab Therapeutics | 20 |
NEXGEL | 19 |
XTL Biopharmaceuticals | 7 |
STIM News
- 1 day ago - Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 8 days ago - Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results - GlobeNewsWire
- 8 days ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results - GlobeNewsWire
- 22 days ago - Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call - GlobeNewsWire
- 5 weeks ago - NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression - GlobeNewsWire
- 6 weeks ago - Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings - PRNewsWire